-
CELGENE CORPORATION v. NATCO PHARMA LIMITED DC
- 2:10-cv-05197
- D.N.J.
- Judge: Susan D. Wigenton
+1
- Filed: 10/08/2010
- Closed: 01/05/2016
- Latest Docket Entry: 01/05/2016
- PACER
1
Plaintiff
3
Defendants
1
Accused
Product
14
Patents-in-Suit
1,916
Days in
Litigation
-
CELGENE CORPORATION v. NATCO PHARMA LIMITED DC
- 2:10-cv-05197
- D.N.J.
- Judge: Susan D. Wigenton
+1
- Filed: 10/08/2010
- Closed: 01/05/2016
- Latest Docket Entry: 01/05/2016
- PACER
Cause of Action
Infringement
Assigned Judge
Outcome Summary
Patent Information
-
Infringement
Arrow International Limited
- 10 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 5 mg, 10 mg, 15 mg, 25 mg lenalidomide capsules | US 5,635,517 A | All Asserted Claims |
Infringement
Entry 466
|
| 5 mg, 10 mg, 15 mg, 25 mg lenalidomide capsules | US 6,045,501 A | All Asserted Claims |
Infringement
Entry 466
|
| 5 mg, 10 mg, 15 mg, 25 mg lenalidomide capsules | US 6,315,720 B1 | All Asserted Claims |
Infringement
Entry 466
|
| 5 mg, 10 mg, 15 mg, 25 mg lenalidomide capsules | US 6,561,976 B2 | All Asserted Claims |
Infringement
Entry 466
|
| 5 mg, 10 mg, 15 mg, 25 mg lenalidomide capsules | US 6,561,977 B2 | All Asserted Claims |
Infringement
Entry 466
|
| 5 mg, 10 mg, 15 mg, 25 mg lenalidomide capsules | US 6,755,784 B2 | All Asserted Claims |
Infringement
Entry 466
|
| 5 mg, 10 mg, 15 mg, 25 mg lenalidomide capsules | US 7,465,800 B2 | All Asserted Claims |
Infringement
Entry 466
|
| 5 mg, 10 mg, 15 mg, 25 mg lenalidomide capsules | US 8,315,886 B2 | All Asserted Claims |
Infringement
Entry 466
|
| 5 mg, 10 mg, 15 mg, 25 mg lenalidomide capsules | US 8,404,717 B2 | All Asserted Claims |
Infringement
Entry 466
|
| 5 mg, 10 mg, 15 mg, 25 mg lenalidomide capsules | US 8,431,598 B2 | All Asserted Claims |
Infringement
Entry 466
|
Natco Pharma Limited
- 10 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 5 mg, 10 mg, 15 mg, 25 mg lenalidomide capsules | US 5,635,517 A | All Asserted Claims |
Infringement
Entry 466
|
| 5 mg, 10 mg, 15 mg, 25 mg lenalidomide capsules | US 6,045,501 A | All Asserted Claims |
Infringement
Entry 466
|
| 5 mg, 10 mg, 15 mg, 25 mg lenalidomide capsules | US 6,315,720 B1 | All Asserted Claims |
Infringement
Entry 466
|
| 5 mg, 10 mg, 15 mg, 25 mg lenalidomide capsules | US 6,561,976 B2 | All Asserted Claims |
Infringement
Entry 466
|
| 5 mg, 10 mg, 15 mg, 25 mg lenalidomide capsules | US 6,561,977 B2 | All Asserted Claims |
Infringement
Entry 466
|
| 5 mg, 10 mg, 15 mg, 25 mg lenalidomide capsules | US 6,755,784 B2 | All Asserted Claims |
Infringement
Entry 466
|
| 5 mg, 10 mg, 15 mg, 25 mg lenalidomide capsules | US 7,465,800 B2 | All Asserted Claims |
Infringement
Entry 466
|
| 5 mg, 10 mg, 15 mg, 25 mg lenalidomide capsules | US 8,315,886 B2 | All Asserted Claims |
Infringement
Entry 466
|
| 5 mg, 10 mg, 15 mg, 25 mg lenalidomide capsules | US 8,404,717 B2 | All Asserted Claims |
Infringement
Entry 466
|
| 5 mg, 10 mg, 15 mg, 25 mg lenalidomide capsules | US 8,431,598 B2 | All Asserted Claims |
Infringement
Entry 466
|
Watson Pharmaceuticals, Inc.
- 10 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 5 mg, 10 mg, 15 mg, 25 mg lenalidomide capsules | US 5,635,517 A | All Asserted Claims |
Infringement
Entry 466
|
| 5 mg, 10 mg, 15 mg, 25 mg lenalidomide capsules | US 6,045,501 A | All Asserted Claims |
Infringement
Entry 466
|
| 5 mg, 10 mg, 15 mg, 25 mg lenalidomide capsules | US 6,315,720 B1 | All Asserted Claims |
Infringement
Entry 466
|
| 5 mg, 10 mg, 15 mg, 25 mg lenalidomide capsules | US 6,561,976 B2 | All Asserted Claims |
Infringement
Entry 466
|
| 5 mg, 10 mg, 15 mg, 25 mg lenalidomide capsules | US 6,561,977 B2 | All Asserted Claims |
Infringement
Entry 466
|
| 5 mg, 10 mg, 15 mg, 25 mg lenalidomide capsules | US 6,755,784 B2 | All Asserted Claims |
Infringement
Entry 466
|
| 5 mg, 10 mg, 15 mg, 25 mg lenalidomide capsules | US 7,465,800 B2 | All Asserted Claims |
Infringement
Entry 466
|
| 5 mg, 10 mg, 15 mg, 25 mg lenalidomide capsules | US 8,315,886 B2 | All Asserted Claims |
Infringement
Entry 466
|
| 5 mg, 10 mg, 15 mg, 25 mg lenalidomide capsules | US 8,404,717 B2 | All Asserted Claims |
Infringement
Entry 466
|
| 5 mg, 10 mg, 15 mg, 25 mg lenalidomide capsules | US 8,431,598 B2 | All Asserted Claims |
Infringement
Entry 466
|